The impact of hemovigilance studies on transfusion practices: Single centre experience
Objective: Blood product transfusion is one of the most commonly used medical interventions worldwide. However, transfusion-related adverse events (TRAEs) can cause morbidity and rarely even mortality. For this reason, hemovigilance studies have recently gained importance in...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Hitit University
2024-10-01
|
| Series: | Hitit Medical Journal |
| Online Access: | https://dergipark.org.tr/tr/doi/10.52827/hititmedj.1506020 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841545364526596096 |
|---|---|
| author | Samet Yaman Gökhan Evren Bilge Zihar Emine Beköz Yurdagül Kökcü Abdulkerim Yıldız |
| author_facet | Samet Yaman Gökhan Evren Bilge Zihar Emine Beköz Yurdagül Kökcü Abdulkerim Yıldız |
| author_sort | Samet Yaman |
| collection | DOAJ |
| description |
Objective: Blood product transfusion is one of the most commonly used medical interventions worldwide. However, transfusion-related adverse events (TRAEs) can cause morbidity and rarely even mortality. For this reason, hemovigilance studies have recently gained importance in terms of safe and effective implementation of transfusion.Material and Method: Transfusion practices issued in the period of 2016-2023 were analyzed retrospectively. All TRAE including adverse reactions (AR) and adverse events (AE) were recorded. The impact of hemovigilance practices on the incidence of TRAE was analyzed by comparing the numbers and types of events between years.Results: In the 8-year period between 2016 and 2023, a total of 135,506 blood products belonging to 45,571 patients were used. 172 adverse reactions (AR) were reported in 170 patients. The overall AR incidence was found to be 126.8 (/100000). The highest yearly AR rate was reported in 2018 with 168.04 (/100000). Since hemovigilance measures were tightened, a statistically significant decrease was recorded in ARs from the beginning of 2020 to date (p |
| format | Article |
| id | doaj-art-8a746a644f8346d2a95378a8e6fb17a3 |
| institution | Kabale University |
| issn | 2687-4717 |
| language | English |
| publishDate | 2024-10-01 |
| publisher | Hitit University |
| record_format | Article |
| series | Hitit Medical Journal |
| spelling | doaj-art-8a746a644f8346d2a95378a8e6fb17a32025-01-12T07:11:01ZengHitit UniversityHitit Medical Journal2687-47172024-10-016334935510.52827/hititmedj.1506020 The impact of hemovigilance studies on transfusion practices: Single centre experience Samet Yaman0https://orcid.org/0000-0003-4081-1070Gökhan Evren1https://orcid.org/0000-0002-3857-1648Bilge Zihar2https://orcid.org/0009-0008-4803-744XEmine Beköz3https://orcid.org/0009-0007-3349-4472Yurdagül Kökcü4https://orcid.org/0009-0004-2668-5041Abdulkerim Yıldız5https://orcid.org/0000-0002-9596-4042HİTİT ÜNİVERSİTESİ, TIP FAKÜLTESİHITIT UNIVERSITYHITIT UNIVERSITYHITIT UNIVERSITYHITIT UNIVERSITYHITIT UNIVERSITY Objective: Blood product transfusion is one of the most commonly used medical interventions worldwide. However, transfusion-related adverse events (TRAEs) can cause morbidity and rarely even mortality. For this reason, hemovigilance studies have recently gained importance in terms of safe and effective implementation of transfusion.Material and Method: Transfusion practices issued in the period of 2016-2023 were analyzed retrospectively. All TRAE including adverse reactions (AR) and adverse events (AE) were recorded. The impact of hemovigilance practices on the incidence of TRAE was analyzed by comparing the numbers and types of events between years.Results: In the 8-year period between 2016 and 2023, a total of 135,506 blood products belonging to 45,571 patients were used. 172 adverse reactions (AR) were reported in 170 patients. The overall AR incidence was found to be 126.8 (/100000). The highest yearly AR rate was reported in 2018 with 168.04 (/100000). Since hemovigilance measures were tightened, a statistically significant decrease was recorded in ARs from the beginning of 2020 to date (phttps://dergipark.org.tr/tr/doi/10.52827/hititmedj.1506020 |
| spellingShingle | Samet Yaman Gökhan Evren Bilge Zihar Emine Beköz Yurdagül Kökcü Abdulkerim Yıldız The impact of hemovigilance studies on transfusion practices: Single centre experience Hitit Medical Journal |
| title |
The impact of hemovigilance studies on transfusion practices: Single centre experience
|
| title_full |
The impact of hemovigilance studies on transfusion practices: Single centre experience
|
| title_fullStr |
The impact of hemovigilance studies on transfusion practices: Single centre experience
|
| title_full_unstemmed |
The impact of hemovigilance studies on transfusion practices: Single centre experience
|
| title_short |
The impact of hemovigilance studies on transfusion practices: Single centre experience
|
| title_sort | impact of hemovigilance studies on transfusion practices single centre experience |
| url | https://dergipark.org.tr/tr/doi/10.52827/hititmedj.1506020 |
| work_keys_str_mv | AT sametyaman theimpactofhemovigilancestudiesontransfusionpracticessinglecentreexperience AT gokhanevren theimpactofhemovigilancestudiesontransfusionpracticessinglecentreexperience AT bilgezihar theimpactofhemovigilancestudiesontransfusionpracticessinglecentreexperience AT eminebekoz theimpactofhemovigilancestudiesontransfusionpracticessinglecentreexperience AT yurdagulkokcu theimpactofhemovigilancestudiesontransfusionpracticessinglecentreexperience AT abdulkerimyıldız theimpactofhemovigilancestudiesontransfusionpracticessinglecentreexperience AT sametyaman impactofhemovigilancestudiesontransfusionpracticessinglecentreexperience AT gokhanevren impactofhemovigilancestudiesontransfusionpracticessinglecentreexperience AT bilgezihar impactofhemovigilancestudiesontransfusionpracticessinglecentreexperience AT eminebekoz impactofhemovigilancestudiesontransfusionpracticessinglecentreexperience AT yurdagulkokcu impactofhemovigilancestudiesontransfusionpracticessinglecentreexperience AT abdulkerimyıldız impactofhemovigilancestudiesontransfusionpracticessinglecentreexperience |